MolNFT v1 · #178454 · DNA
Discovery of DS15060524; gene targeting chimera (genetac) for the treatment of FRIEDREICH'S ataxia (frda)
7FGT: “Discovery of DS15060524; gene targeting chimera (genetac) for the treatment of FRIEDREICH'S ataxia (frda)”. Solution nmr, 1 ligand (5R3). MolNFT v1 #178454 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 7FGT
- Type
- DNA
- Length
- 18 nucleotides
- Chains
- 2
- Method
- solution nmr
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Ligands
- 5R3
Structure
solution nmr · 2 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | dna | 9 | — | — |
| B | — | dna | 9 | — | — |
Ligands and binding sites
- 5R3 · ~{N}-[3-[3-(dimethylamino)propylamino]-3-oxidanylidene-propyl]-1-methyl-4-[3-[[1-methyl-4-[[1-methyl-4-[3-[[1-methyl-4-[(1-methylimidazol-2-yl) carbonylamino]pyrrol-2-yl]carbonylamino]propanoylamino]imidazol-2-yl]carbonylamino]pyrrol-2-yl]carbonylamino]propanoylamino]imidazole-2-carboxamide · ligand · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 7FGT · Discovery of DS15060524; Gene targeting chimera (GeneTAC) for the treatment of… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 7FGT · PDBe 7FGT
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.